Autoplay
Autocomplete
Previous Lesson
Complete and Continue
ICH E6 (R2) Investigator Site Personnel Training
Introduction
Introduction to Pharma Training Hub, ClinOpsHub CRO and Meet Your Trainers (2:54)
The importance of GCP training and TransCelerate Certificate Compliance (1:17)
The Agenda (0:30)
Section 1: Main Stakeholders in Clinical Research
Stakeholder Definitions (3:05)
Who are the Main Stakeholders? (0:50)
Review Quiz 1
Section 2: Good Clinical Practice (GCP) (a Brief Summary)
E6 - Efficacy Guidelines (3:24)
GCP Definition and Introduction to ICH (2:03)
Guidelines, Local Law, Regulations (1:22)
Why? The declaration of Helsinki (3:39)
Why Was a Revision 2 Necessary? (2:03)
The 8 GCP Chapters (3:03)
Review Quiz 2
Section 3: The Principles of GCP
The Trial Centre (4:14)
The Fundamental Principles (2:03)
Review Quiz 3
Section 4: Investigator Responsibilities
Quality Control (2:36)
Investigator's Responsibility (2:10)
Adequate Resources (4.2) (1:37)
Medical Care of Trial Subjects (4.3) (1:34)
Communication with IRB-IEC (4.4) (1:48)
Compliance with Protocol (4.5) Part 1 (0:24)
Investigator Statement (signature page) (2:50)
Compliance with Protocol (4.5) Part 2 (1:36)
Investigational Product(s) (4.6) (1:17)
Randomization Procedures and Unblinding (4.7) (0:46)
Informed Consent of Trial Subject (4.8) (6:48)
Vulnerable Subjects (1.61) (3:30)
Informed Consent of Trial Subject (4.8) Part 2 (2:46)
Records and Reports (4.9) (7:16)
Progress Reports and Final Reports (4.10, 4.13) (2:00)
Safety Reporting (4.11) (4:00)
Early Trial Termination (4.12) and Course Conclusion (3:30)
Final graded QUIZ
Did you like this course?
Did you like this course, was it helpful? Tell us about it.
Why? The declaration of Helsinki
Lesson content locked
If you're already enrolled,
you'll need to login
.
Enroll in Course to Unlock